Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage

Critical Care Medicine

Volumn 35, Issue 10, 2007, Pages 2383-2389

  Naidech, Andrew M ^a,c   Jovanovic, Borko ^b   Wartenberg, Katja E ^a,e   Parra, Augusto ^a,c   Ostapkovich, Noeleen ^a   Connolly, E Sander ^a   Mayer, Stephan A ^a   Commichau, Christopher ^a,d  

^a NEUROLOGICAL INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e University of Texas Health Science Center ^*

Author keywords

Anemia; Cerebrovascular disorders; Disability; Outcomes; Subarachnoid hemorrhage; Transfusion

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BRAIN INFARCTION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE REGISTRY; ELECTRONIC MEDICAL RECORD; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; INFORMATION RETRIEVAL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK REDUCTION; SAMPLE SIZE; SUBARACHNOID HEMORRHAGE;

FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 34748859202     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000284516.17580.2C     Document Type: Article

References (33)

1. International Subarachnoid Hemorrhage Trial Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised trial. Lancet 2002; 360:1267-1274
2. Naidech AM, Janjua N, Kreiter KT, et al: Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005; 62:410-416
3. Janjua N, Mayer SA: Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 2003; 9:113-119
4. von Ahsen N, Muller C, Serke S, et al: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-2639
5. Rodriguez RM, Corwin HL, Gettinger A, et al: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16:36-41
6. Burnum JF: Medical vampires. N Engl J Med 1986; 314:1250-1251
7. Corwin HL, Gettinger A, Pearl RG, et al: The CRIT Study: Anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004; 32:39-52
8. Adam RC, Lundy JS: Anesthesia in cases of poor risk: Some suggestions for decreasing the risk. Surg Gynecol Obstet 1942; 74:1011-1101
9. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
10. Giller CA, Wills MJ, Giller AM, et al: Distribution of hematocrit values after aneurysmal subarachnoid hemorrhage. J Neuroimaging 1998; 8:169-170
11. Wartenberg KE, Schmidt MJ, Claassen J, et al: Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006; 34:617-623
12. Smith MJ, Le Roux PD, Elliott JP, et al: Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004; 101:1-7
13. Naidech AM, Drescher J, Ault ML, et al: Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006; 59:775-780
14. Ekelund A, Reinstrup P, Ryding E, et al: Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2002; 144:703-712
15. Thomas DJ, Marshall J, Russell RW, et al: Effect of haematocrit on cerebral blood-flow in man. Lancet 1977; 2:941-943
16. Tu YK, Kuo MF, Liu HM: Cerebral oxygen transport and metabolism during graded isovolemic hemodilution in experimental global ischemia. J Neurol Sci 1997; 150:115-122
17. Smith MJ, Stiefel MF, Magge S, et al: Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005; 33:1104-1108
18. Kreiter KT, Copeland D, Bernardini GL, et al: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 2002; 33:200-208
19. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28:14-20
20. Hijdra A, van Gijn J, Nagelkerke NJ, et al: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 1988; 19:1250-1256
21. van Swieten JC, Koudstaal PJ, Visser MC, et al: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607
22. Nguyen Ba V, Peres Bota D, Melot C, et al: Time course of hemoglobin concentrations in non-bleeding ICU patients. Crit Care Med 2003; 31:406-410
23. Vincent JL, Piagnerelli M: Transfusion in the ICU. Crit Care Med 2006; 34:S96-S101
24. Murrell Z, Haukoos JS, Putnam B, et al: The effect of older blood on mortality, need for ICU care, and the length of ICU stay after major trauma. Am Surg 2005; 71:781-785
25. Shimosegawa E, Hatazawa J, Ibaraki M, et al: Metabolic penumbra of acute brain infarction: A correlation with infarct growth. Ann Neurol 2005; 57:495-504
26. Sobesky J, Zaro Weber O, Lehnhardt FG, et al: Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005; 36:980-985
27. Sakoh M, Ostergaard L, Rohl L, et al: Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: Sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs. J Neurosurg 2000; 93:647-657
28. Morimoto Y, Mathru M, Martinez-Tica JF, et al: Effects of profound anemia on brain tissue oxygen tension, carbon dioxide tension, and pH in rabbits. J Neurosurg Anesthesiol 2001; 13:33-39
29. McKinley BA, Morris WP, Parmley CL, et al: Brain parenchyma PO2, PCO2, and pH during and after hypoxic, ischemic brain insult in dogs. Crit Care Med 1996; 24:1858-1868
30. Zauner A, Bullock R, Di X, et al: Brain oxygen, CO2, pH, and temperature monitoring: Evaluation in the feline brain. Neurosurgery 1995; 37:1168-1176
31. Buemi M, Grasso G, Corica F, et al: In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J. Pharmacol 2000; 392:31-34
32. Grasso G, Buemi M, Alafaci C, et al: Benefi-cial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 2002; 99:5627-5631
33. Kirkpatrick PJ, Tseng MY: Erythropoietin therapy for subarachnoid hemorrhage. Available at: http://clinicaltrials.gov/ct/show/NCT00140010?order=1. Accessed August 9, 2007